Email Updates

You are here

Home

31 MAY 2019 VOLUME 20 ISSUE 21

Media Coverage

  • Old Fight, New Front: AIDS Activists Want Lower Drug Prices. Now!

    When the first HIV drug, AZT, came to market in 1987, it cost $10,000 a year.... At the time, the price Burroughs Wellcome set for the drug sparked outrage. The AIDS epidemic was an urgent national crisis. For many, the diagnosis was a death sentence. The TV-viewing public was horrified by endless images of young men, suddenly sick and dying. A lost generation.

    May 30, 2019
    PrEP, Treatment
    WNYC

  • Targeted Response Needed to Fight HIV Within Nations

    The striking variation in HIV prevalence at provincial and district levels across countries in Sub-Saharan African calls for targeted interventions, a study suggests.

    May 30, 2019
    General
    SciDevNet

  • NACA Seeks Prevention of New HIV Infections

    The outcome of the preliminary findings of the Nigerian HIV/AIDS Indicator and Impact Survey, NAIIS, has revealed that HIV prevalence was highest among women aged 35 and 49 with 3.3 percent and males aged 50 and above with 2.0 percent.

    May 30, 2019
    General
    Vanguard

  • California May Make Anti-HIV Drug Available Without Prescription for 30 Days

    Pharmacies throughout California could soon dispense an HIV-prevention drug without a doctor’s prescription — a move a San Francisco state senator says is necessary to remove barriers to people’s access to medication that could end new infections.

    May 30, 2019
    PrEP
    San Francisco Chronicle

  • HIV Prevention Pill to Get Insurance Benefit in Korea

    The Ministry of Health and Welfare on Tuesday said it would grant insurance benefit for Truvada HIV-1 PrEP used for people who are negative in HIV-1 infection but at high risk due to sex with an HIV-positive partner, starting from June 7.

    May 30, 2019
    PrEP
    Korea Biomedical Review

  • Fighting the Gender Stereotypes That Warp Biomedical Research

    Female animals were once deemed too hormonal and messy for science. Some scientists warn it’s not enough to just use more female lab rats.

    May 30, 2019
    General
    New York Times

  • First Ladies Can Help Lead the Fight Against HIV/AIDS

    Complacency, the United Nations warned in its latest report on AIDS, constitutes a grave threat to decades of progress against HIV. The report, a self-proclaimed “wake-up call,” was directed at the entire global health community. But its message is particularly urgent and personal for African women, who bear the brunt of the HIV pandemic but who are also in the vanguard of the fight against it.

    May 29, 2019
    General
    STAT News

  • Over a Million Girls to to Get HPV Vaccine This Week

    Over a million girls are set to receive the Human Papilloma Virus (HPV) vaccine this week in Zimbabwe, a development likely to reduce the number of new cervical cancer cases.

    May 29, 2019
    HPV Vaccines
    Chronicle

  • Drug Trial in Cuba to Prevent HIV Infections

    The city of Cardenas has become Cuba’s trial-ground for a pilot experiment to prevent the transmission of the human immunodeficiency virus (HIV), the cause of AIDS, which if results are positive, could be implemented nationwide very soon.

    May 29, 2019
    PrEP
    Havana Times

  • Half of HIV Patients Are Women. Most Research Subjects Are Men

    Inspired by reports of a second patient apparently freed of infection with HIV, the virus that causes AIDS, scientists are pursuing dozens of ways to cure the disease. But now, researchers must reckon with a longstanding obstacle: the lack of women in clinical trials of potential HIV treatments, cures and vaccines.

    May 28, 2019
    General
    New York Times

  • WHO Agrees Watered-Down Resolution on Transparency in Drug Costs

    World Health Organization members agreed on Tuesday to push for clearer drug pricing but stepped back from proposals by activists to force pharmaceutical firms to disclose the cost of making medicines.

    May 28, 2019
    General
    Reuters

  • Exposure to HIV Treatment During Breastfeeding Does Not Impact Infant Neurodevelopment

    Infants exposed to their mother’s antiretroviral treatment (ART) pre- and post-partum do not experience any significant poorer neurocognitive development compared to HIV-negative infants who are never exposed to HIV treatment, reassures a new study.

    May 28, 2019
    Treatment
    Avert

  • Nearly Half a Million Adults Are HIV-Positive in Johannesburg – Study

    The study found South Africa’s HIV adult prevalence rate was much higher than most other countries, including Kenya (5.6 percent), Nigeria (3 percent), Namibia (13.8 percent), Zimbabwe (13.5 percent) and Mozambique (11.9 percent). But according to the research, South Africa’s high rate is partly because more people are living longer with HIV due to antiretroviral therapies.

    May 28, 2019
    General
    IOL

  • Generics Not Only Cheap but Safe, Effective

    Barely months after the uproar caused by a Kenyan insurance company’s directive that doctors only prescribe generic medicines, the generic-versus-branded drugs debate has once again been resurrected by events thousands of miles away.

    May 27, 2019
    PrEP, Treatment
    Daily Nation

  • Working Toward a Cure for HIV: Where Are We?

    The landscape of HIV treatment continues to shift and grow, with new and streamlined therapies introduced on a regular basis. People living with HIV today can lead very different lives than those of people who were diagnosed in the ’90s and early 2000s. Antiretroviral therapy (ART) makes it possible for a person living with HIV to experience complete viral suppression, even engaging in condomless sexual intercourse, or gestating a baby without fear of passing on the virus (Undetectable=Untransmittable).

    May 24, 2019
    Cure
    Contagion Live

Published Research

Announcements